Clonidine overdose in childhood: implications of increased prescribing

C Kappagoda1, D N Schell, R M Hanson

  • 1Royal Alexandra Hospital for Children, Parramatta, New South Wales, Australia.

Insights

Clonidine overdose cases, particularly in children treated for attention-deficit hyperactivity disorder (ADHD), are increasing and require intensive care. Awareness and preventive strategies are crucial to reduce these incidents.

Area of Science:

  • Pediatric Toxicology
  • Clinical Pharmacology

Background:

  • Clonidine is increasingly prescribed for Attention-Deficit Hyperactivity Disorder (ADHD).
  • A rise in clonidine overdose admissions to pediatric hospitals has been observed.

Purpose of the Study:

  • To analyze the trend of clonidine overdose cases in a pediatric hospital.
  • To detail the clinical presentation, course, and circumstances of clonidine overdoses.

Main Methods:

  • Retrospective review of emergency department, ICU, and inpatient databases.
  • Analysis of case notes for clinical features, history, and outcomes.

Main Results:

  • Fifteen patients experienced 16 clonidine overdoses between 1990-1997, with a significant increase after 1994.
  • Common symptoms included depressed consciousness (75%) and bradycardia (88%).
  • Fourteen overdoses were linked to ADHD medication, with no fatalities.

Conclusions:

  • Clonidine overdose is a growing concern in pediatric care, often necessitating intensive care.
  • Increased use for ADHD treatment is a contributing factor.
  • Preventive measures, including patient selection and packaging changes, are recommended.
Abstract

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...